Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Ramage

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Chemical Communications (Cambridge, England)|January 25, 2021
Dyeing fungi: amphotericin B based fluorescent probes for multiplexed imagingAssel Baibek, Muhammed Üçüncü, Bryn Short, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2008
Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilmsEilidh Mowat, Sue Lang, Craig Williams, et al.
Applied and Environmental Microbiology|October 31, 2002
Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing moleculeGordon Ramage, Stephen P Saville, Brian L Wickes, et al.
Npj Antimicrobials and Resistance|October 1, 2025
The butterfly effect: collateral damage and impacts of antimicrobial strategies on the oral microbiomeJason L Brown, William Johnston, Mark C Butcher, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Activity of pyocin S2 against Pseudomonas aeruginosa biofilmsKaren Smith, Laura Martin, Angela Rinaldi, et al.
Antibiotics (Basel, Switzerland)|November 2, 2019
<i>Candida albicans</i> Biofilm Heterogeneity and Tolerance of Clinical Isolates: Implications for Secondary Endodontic InfectionsOm Alkhir Alshanta, Suror Shaban, Christopher J Nile, et al.
International Journal of Antimicrobial Agents|February 26, 2017
Efficacy of rifampicin combination therapy for the treatment of enterococcal infections assessed in vivo using a Galleria mellonella infection modelKirsty Skinner, Jonathan A T Sandoe, Ranjith Rajendran, et al.
Oral Oncology|February 21, 2006
Susceptibility to Melaleuca alternifolia (tea tree) oil of yeasts isolated from the mouths of patients with advanced cancerJeremy Bagg, Margaret S Jackson, M Petrina Sweeney, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2013
Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilmsGordon Ramage, Anto Jose, Leighann Sherry, et al.
Journal of Medical Microbiology|July 17, 2008
Biofilm formation by Scottish clinical isolates of Staphylococcus aureusKaren Smith, Ana Perez, Gordon Ramage, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Chemical Communications (Cambridge, England)|January 25, 2021
Dyeing fungi: amphotericin B based fluorescent probes for multiplexed imagingAssel Baibek, Muhammed Üçüncü, Bryn Short, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2008
Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilmsEilidh Mowat, Sue Lang, Craig Williams, et al.
Applied and Environmental Microbiology|October 31, 2002
Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing moleculeGordon Ramage, Stephen P Saville, Brian L Wickes, et al.
Npj Antimicrobials and Resistance|October 1, 2025
The butterfly effect: collateral damage and impacts of antimicrobial strategies on the oral microbiomeJason L Brown, William Johnston, Mark C Butcher, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Activity of pyocin S2 against Pseudomonas aeruginosa biofilmsKaren Smith, Laura Martin, Angela Rinaldi, et al.
Antibiotics (Basel, Switzerland)|November 2, 2019
<i>Candida albicans</i> Biofilm Heterogeneity and Tolerance of Clinical Isolates: Implications for Secondary Endodontic InfectionsOm Alkhir Alshanta, Suror Shaban, Christopher J Nile, et al.
International Journal of Antimicrobial Agents|February 26, 2017
Efficacy of rifampicin combination therapy for the treatment of enterococcal infections assessed in vivo using a Galleria mellonella infection modelKirsty Skinner, Jonathan A T Sandoe, Ranjith Rajendran, et al.
Oral Oncology|February 21, 2006
Susceptibility to Melaleuca alternifolia (tea tree) oil of yeasts isolated from the mouths of patients with advanced cancerJeremy Bagg, Margaret S Jackson, M Petrina Sweeney, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2013
Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilmsGordon Ramage, Anto Jose, Leighann Sherry, et al.
Journal of Medical Microbiology|July 17, 2008
Biofilm formation by Scottish clinical isolates of Staphylococcus aureusKaren Smith, Ana Perez, Gordon Ramage, et al.
Pageof 19